Inside Science
Inside Science: Consorting with Cohorts
Published on October 31, 2024In the Dog Aging Project, our different cohorts are different groups of dogs with characteristics that allow us to ask and seek answers to specific scientific questions.
Read MoreInside TRIAD: A Closer Look a the TRIAD Cohort
Published on October 28, 2024The TRIAD clinical trial is a nationwide, double-blind veterinary clinical trial. This means half the dogs will receive the medication under study, and half will receive a placebo. In this trial, we will study the effects of the medication rapamycin.
Read MoreInside Science: Canine Sentinels
Published on October 25, 2024In this article at Science.org, our Dog Aging Project team members Courtney Sexton and Audrey Ruple lay the framework for how our close relationships with canine companions can offer an opportunity to learn how the combined elements of the physical and social environment contribute to the quality of life for both people and dogs.
Read MoreInside TRIAD: A Deeper Dive into the Test of Rapamycin In Aging Dogs
Published on October 24, 2024In the TRIAD study, we hope to evaluate the safety, efficacy, and potential side effects of rapamycin in dogs, leading to improved veterinary care of senior dogs and contributions to the understanding of human aging.
Read MoreIt Takes a Village to Publish a Paper!
Published on July 30, 2024If you have ever read a paper in a scientific journal, you have seen the…
Read MoreInside TRIAD: Introducing the Test of Rapamycin in Aging Dogs
Published on September 20, 2023Many of the insights the Dog Aging Project gathers are through its surveys and activities; however, we also gain valuable information from the veterinary electronic medical records (VEMRs) that we receive. Submission of a VEMR is not necessary to enroll in the Dog Aging Project longitudinal observational study, but some of our smaller cohorts like Precision and TRIAD do require eligible VEMRs for consideration.
Read More